Dead vaccine – Valneva chief urgently warns unvaccinated! “Don’t do it!”
In Germany, just under 70 percent of the population has so far been vaccinated against the coronavirus. This ensures that among those who have not yet been vaccinated, the infection figures are rising sharply. Among them are partly even people from risk groups who do not trust the novel vaccines, Many of the vaccination opponents are apparently waiting for the approval of a dead vaccine.
Dead vaccines are widely used
Because while vector vaccines such as AstraZeneca’s and Moderna’s vaccines and mRNA vaccines such as Moderna’s and Biontech/Pfizer’s are more or less new technological territory, dead vaccines have been used in other vaccinations for a long time. For example, dead vaccines are administered against the flu, tetanus or hepatitis, among others. “Dead vaccines contain killed pathogens, i.e. pathogens that are no longer capable of reproducing. This also includes vaccines that contain only components or individual molecules of these pathogens. Depending on the method of production and the degree of purification, these vaccines are referred to as whole-virus, split-virus or subunit vaccines. Examples are vaccines against hepatitis A (whole-virus) and influenza (split- and subunit vaccines),” an expert explains the different vaccines
Valneva CEO warns: “I don’t advise anyone to wait for our vaccine”
However, in view of the critical situation with the high infection figures at the moment, those willing to be vaccinated should not lose any more time and get vaccinated immediately. It is true that the first inactivated vaccine, Valneva, will soon be approved. But until the drug agency EMA approves it and vaccination then becomes possible in EU member states, valuable time could be lost. “I do not advise anyone to wait for our vaccine,” clarifies Valneva CEO Thomas Lingenbach now at the magazine “We”. Even Lingenbach describes waiting for the dead vaccine as “ethically unacceptable”. “Get vaccinated now,” Lingenbach therefore appealed to all unvaccinated people. Because an exact date when the dead vaccine will be widely available cannot be predicted. Lingenbach himself confirms that he last received a booster vaccination with the Biontech vaccine.
EU has signed deal with Valneva
At present, the accelerated approval procedure for Valneva’s vaccine is underway at the EMA. In addition, the EU has already ordered more than 60 million vaccine doses from Valneva. US-based Novavax also has an ongoing approval process with the EMA. But the company had recently contradicted that its vaccine was a dead vaccine. The EU has also ordered more than 100 million doses of vaccine from Novavax. But now Novavax writes on its own website that its own vaccine is a protein-based vaccine. So not really a dead vaccine? In this context, the new Minister of Health, Karl Lauterbach, has a whole thesis of his own as to why the American company’s vaccine is being called a dead vaccine: “Because so many unvaccinated people only want dead vaccine, for whatever reason, soon-to-be-available Novavax is being referred to as such,” Lauterbach writes on his Twitter profile.